Vertex Pharmaceuticals logo

Vertex Pharmaceuticals(VRTX)

Leader

Vertex Pharmaceuticals (VRTX) reported $10.7B revenue in FY2024, up 12% YoY. Global leader in cystic fibrosis treatment. Near-monopoly on CF drugs. HQ: Boston, MA. Market cap ~$110B.

78
AI Score
Grade B
AI Visibility Score (Beta)
HealthcareEnterpriseVRTXWebsiteUpdated November 2026

Brand Intelligence Graphcompany

Company Overview

About Vertex Pharmaceuticals

Vertex Pharmaceuticals Incorporated is a global biotechnology company and the world's undisputed leader in cystic fibrosis (CF) treatment, headquartered in Boston, Massachusetts. Founded in 1989 by Joshua Boger, Vertex pioneered the development of CFTR modulators — drugs that target the underlying cause of CF (a defective protein) rather than just managing symptoms. The company reported revenues of $10.7B in FY2024, up 12% year-over-year, with a near-monopoly on the CF treatment market.

Business Model & Competitive Advantage

Vertex's CF franchise is built on a succession of increasingly effective CFTR modulator drugs: Kalydeco (2012), Orkambi (2015), Symdeko/Symkevi (2018), and Trikafta/Kaftrio (2019) — the latter treating up to 90% of CF patients and generating over $9B in annual revenue alone. Trikafta has been transformational for the 40,000+ CF patients in the US and 90,000+ globally, dramatically improving lung function and quality of life. Beyond CF, Vertex is expanding into new therapeutic areas with significant pipeline assets: exa-cel (a gene-editing therapy with CRISPR Therapeutics for sickle cell disease, now approved as Casgevy), non-opioid pain treatment (suzetrigine/VX-548, approved January 2025 as Journavx), and kidney disease (VX-147 for APOL1-mediated kidney disease).

Competitive Landscape 2025–2026

Vertex trades on NASDAQ (VRTX) with a market cap of approximately $110B and has one of the strongest balance sheets in biotech (~$12B in cash). CEO Reshma Kewalramani has expanded the company's ambition from a single-disease franchise to a multi-disease platform company, with the non-opioid pain drug Journavx representing a potential blockbuster in a market worth $15B+.

Founded
1989
Headquarters
Boston, Massachusetts
Revenue
$10.7B
Curated content • Fact-checked and verified

Recent Activity

View all →

Key Differentiators

Market Leader

Vertex Pharmaceuticals is recognized as a market leader in the Healthcare Tech sector, demonstrating strong industry presence and customer trust.

Enterprise Scale

With $10.7B in revenue, Vertex Pharmaceuticals operates at enterprise scale with proven market validation.

Frequently Asked Questions

Estimated Visibility Trend (Beta)

Simulated 8-week rolling score

78
→ Stable

Based on estimated brand signals. Historical tracking coming soon.

Similar Brands

Pfizer logo

Pfizer

Healthcare Tech
B2bHealthtechManufacturingSaasPublic

Pfizer is one of the world's largest biopharmaceutical companies, founded in 1849 by cousins Charles Pfizer and Charles Erhart in Brooklyn, New York, and now headquartered in New York City. The compan

Moderna logo

Moderna

Healthcare Tech
B2bHealthtechManufacturingSaasPublic

Moderna is a clinical-stage biotechnology company that pioneered the development of messenger RNA (mRNA) therapeutics and vaccines, founded in 2010 by Noubar Afeyan, Robert Langer, Kenneth Chien, Stép

BNY Mellon logo

BNY Mellon

Consumer Finance
B2cFintechGlobalPublic

BNY Mellon—rebranded as BNY in 2024—is the world's largest custodian bank and a global leader in investment services, tracing its origins to the Bank of New York founded in 1784 by Alexander Hamilton.

Amgen logo

Amgen

Healthcare Tech
B2bHealthtechManufacturingSaasPublic

Amgen Inc. is one of the world's largest biotechnology companies, headquartered in Thousand Oaks, California. Founded in 1980 as Applied Molecular Genetics, Amgen pioneered the development of biologic

Veeva Systems logo

Veeva Systems

Healthcare Tech
B2bHealthtechSaasPublic

Veeva Systems Inc. is the leading cloud software provider for the global life sciences industry, headquartered in Pleasanton, California. Founded in 2007 by Peter Gassner (a former Salesforce executiv

Zocdoc logo

Zocdoc

HealthTech
AnalyticsB2bB2cHealthtechMarketplaceMobile FirstPlatformSaas

Zocdoc operates a two-sided marketplace connecting patients with physicians, dentists, and mental health providers who accept their specific insurance and have real-time appointment availability. Pati

For Vertex Pharmaceuticals

Claim This Profile

Are you from Vertex Pharmaceuticals? Verify your company email to claim this profile and keep its description, products, and FAQs up to date.

Claim Vertex Pharmaceuticals Profile →
For competitors & analysts

Track AI Visibility in Real Time

Monitor how ChatGPT, Gemini, Perplexity, and Claude mention Vertex Pharmaceuticals vs competitors. Get alerts when AI recommendations shift.

Start Free Tracking →